白细胞介素12在伯氏疟原虫红细胞内期感染中的免疫调节作用

被引:5
作者
陈姝
陆惠民
张山鹰
高琪
唐学恒
孙臻安
机构
[1] 苏州大学医学院寄生虫学教研室
[2] 福建省疾病预防控制中心
[3] 江苏省寄生虫病防治研究所
[4] 苏州大学医学院寄生虫学教研室 江苏
[5] 江苏
[6] 福州
[7] 无锡
关键词
白细胞介素12; 伯氏疟原虫; 红细胞内期; 免疫保护; 毒副反应;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[目的 ]探讨白细胞介素 12 (IL 12 )在伯氏疟原虫 (P berghei)红细胞内期感染中的免疫调节作用。[方法 ]BALB/c小鼠接种 5× 10 5个感染P berghei的RBC ,分别以不同剂量 ( 0 0 1、0 0 3、0 10和 0 15 μg/d)IL 12 ,或分别在不同给药时间 (感染前 1d、感染同时、感染后第 3d)给予 0 0 3 μg/dIL 12 ,各组均连续用药 6d。观察各组小鼠原虫血症变化及存活时间。[结果 ]与对照组比较 ,较低剂量 ( 0 0 1或 0 0 3 μg/d)IL 12均可显著推迟血中原虫的出现及原虫血症达峰值的时间 ,但仅 0 0 3 μg/d剂量可明显提高生存率 ;较惯剂量 ( 0 1或 0 15 μg/d)IL 12则增加原虫密度 ,加速小鼠死亡。在感染的第 3d给予 0 0 3 μg/dIL 12 ,对原虫血症、生存率均无明显影响。IL 12不能改变感染的结局 ,最终各组小鼠均死亡。[结论 ]IL 12具有免疫保护和毒副反应双重活性。诱导保护作用而减少毒副作用 ,剂量及给药时间是关键 ,适时地给予适当剂量的IL 12可诱导抗红内期疟原虫的部分保护作用。
引用
收藏
页码:1 / 4
页数:4
相关论文
共 13 条
[1]  
Response of human natural killer (NK) cell to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. Robertson MJ,Soiffer RJ,Wolf SF,et al. The Journal of Experimental Medicine . 1992
[2]  
Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer. Portielje JE,Kruit WH,Schuler M,et al. Clinical Cancer Research . 1999
[3]  
Effects of IL-12 on the response and susceptibility to experimental viral infections. Orange JS,Wolf SF,Biron CA,et al. J Immunol . 1994
[4]  
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. Kobayashi M,Fitz L,Ryan M,et al. The Journal of Experimental Medicine . 1989
[5]  
Interleukin-12: biologic activity, therapeutic utility, and role in disease. Hendrzak JA,Brunda MJ. Laboratory Investigation . 1995
[6]  
Induction of interferon production by natural killer cell stimulatory factor: charaterization of the responder cells and synergy with other inducers. Chan SH,Perussia B,Gupta JW,et al. The Journal of Experimental Medicine . 1991
[7]  
Interferon -independent effects of interleukin-12 administered during acute or established infection due to Leishmania major. Wang ZE,Zheng S,Corry DB,et al. Proceedings of the National Academy of Sciences of the United States of America . 1994
[8]  
Natural killer (NK) cell stimulatory factory increases the cytotoxic Activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. Chehimi BJ,Starr SE,Frank I,et al. The Journal of Experimental Medicine . 1991
[9]  
Rat peritoneal mast cells produce IFN- following IL-12 treatment but not in response to IgEmediated activation. Gupta AA,Croitoru K,Marshall JS,et al. J Immunol . 1996
[10]  
Medchanisms of IFN- induction by natural killer cell stimulatory factor (NKSF/Il-12). Chan SH,Kobayashi M,Santoli D,et al. J Immunol . 1992